Centessa Pharmaceuticals Plc ADR (CNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 6,853 | 0 | 0 | 0 |
| Gross Profit | N/A | 6,853 | N/A | N/A | N/A |
| Operating Expenses | 201,055 | 178,136 | 212,263 | 374,867 | 10,440 |
| Operating Income | -201,055 | -171,283 | -212,263 | -374,867 | -10,440 |
| Interest Expense | 10,090 | 9,906 | 7,277 | 1,181 | 68 |
| Other Income | -21,768 | 5,048 | 2,586 | -5,738 | -155 |
| Pre-tax Income | -232,913 | -176,141 | -216,954 | -381,786 | -10,663 |
| Income Tax | 2,844 | -25,056 | -747 | 114 | N/A |
| Net Income Continuous | -235,757 | -151,085 | -216,207 | -381,900 | -10,663 |
| Net Income | $-235,757 | $-151,085 | $-216,207 | $-381,900 | $-10,663 |
| EPS Basic Total Ops | -2.06 | -1.57 | -2.31 | -5.08 | N/A |
| EPS Basic Continuous Ops | -2.06 | -1.57 | -2.31 | -5.08 | N/A |
| EPS Diluted Total Ops | -2.06 | -1.57 | -2.31 | -5.08 | N/A |
| EPS Diluted Continuous Ops | -2.06 | -1.57 | -2.31 | -5.08 | N/A |
| EPS Diluted Before Non-Recurring Items | -1.49 | -1.57 | -2.31 | N/A | N/A |
| EBITDA(a) | $-200,113 | $-170,473 | $-212,132 | $-374,833 | $-10,440 |